Carboplatin: all 1,466 studies that test it
Page 12 of 15. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00702572Phase 1
- Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal CarcinomaCompletedNCT00697905Phase 2
- The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian PatientsCompletedNCT00695994Phase 2
- Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast CancerCompletedNCT00691379Phase 1/2
- Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal CancerStatus unknownNCT00690872Phase 2
- Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerCompletedNCT00687817Phase 2
- Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine CarcinosarcomaCompletedNCT00687687Phase 2
- Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung CancerCompletedNCT00686985Phase 2
- A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) PatientsCompletedNCT00675545Phase 2
- Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)Status unknownNCT00669747Phase 2
- Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian CancerStatus unknownNCT00660842Phase 3
- Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder CancerCompletedNCT00660140Phase 2
- Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free IntervalStatus unknownNCT00657878Phase 3
- Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00652691Phase 1
- Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginStatus unknownNCT00652119Phase 1
- Efficacy Study of CYT997 in Combination With Carboplatin in GlioblastomaTerminatedNCT00650949Phase 1/2
- Phase 1 Study of MPC-6827 and Carboplatin in Recurrent/Relapsed Glioblastoma MultiformeStatus unknownNCT00635557Phase 1/2
- Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00616031Phase 2
- Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix CancerWithdrawnNCT00600210Phase 2
- Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by SurgeryTerminatedNCT00589238Phase 2
- Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersCompletedNCT00588991Phase 1
- Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
- CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLWithdrawnNCT00576225Phase 3
- Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid TumorsCompletedNCT00573690Phase 1
- Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before SurgeryStatus unknownNCT00563160Phase 2
- Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian CancerWithdrawnNCT00562185Phase 1/2
- LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid TumorsCompletedNCT00556088Phase 1
- Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord TumorsCompletedNCT00541138Phase 2
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerCompletedNCT00535119Phase 1
- BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
- Triple Negative Breast Cancer TrialStatus unknownNCT00532727Phase 3
- Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian CancerCompletedNCT00529022Phase 1
- A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00528619Phase 1
- Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/DocetaxelCompletedNCT00527449Phase 2
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00520000Phase 1
- Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelCompletedNCT00516724Phase 1
- A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell TransplantTerminatedNCT00515138Early Phase 1
- Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/ChemotherapyTerminatedNCT00505492Phase 2
- Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid TumorsCompletedNCT00502892Phase 1
- Phase I Study in Patients With Solid TumoursCompletedNCT00496028Phase 1
- Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell CancerActive, not recruitingNCT00494182Phase 2
- Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant GliomasStatus unknownNCT00492687Phase 2
- Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
- Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerCompletedNCT00486356Phase 1
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
- Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus SorafenibTerminatedNCT00473486Phase 1/2
- Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast CancerTerminatedNCT00470249Phase 2
- Enzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWithdrawnNCT00469976Phase 2
- Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerTerminatedNCT00465907Phase 2
- Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerStatus unknownNCT00462397Phase 2
- Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer PatientsTerminatedNCT00453635Phase 2
- Gemcitabine + Carboplatin in Breast CancerCompletedNCT00450762Phase 2
- Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerCompletedNCT00449020Phase 2
- Velcade Plus ICE for Patients With Relapsed Classical Hodgkin LymphomaCompletedNCT00439361Phase 1
- VinCaT: Vinorelbine, Carboplatin and Trastuzumab in Advanced Her-2 Positive Breast CancerStatus unknownNCT00431704Phase 2
- Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)CompletedNCT00430651Phase 3
- A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid TumorsCompletedNCT00422682Phase 1
- Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00415116Phase 1
- Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial CancerActive, not recruitingNCT00411138Phase 3
- Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
- Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural MesotheliomaCompletedNCT00407459Phase 2
- ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CarcinomaTerminatedNCT00407407Phase 1
- MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian CancerCompletedNCT00401674Phase 2
- END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal DoxorubicinCompletedNCT00401635Phase 2
- Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)CompletedNCT00388076Phase 1
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
- Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or CarboplatinWithdrawnNCT00369954Phase 2
- Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
- Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade GliomaCompletedNCT00352495Phase 1
- ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant GliomaCompletedNCT00352313Phase 1/2
- Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerCompletedNCT00352300Phase 1
- A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer PatientsCompletedNCT00340184Phase 2
- Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00334763Phase 2
- Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer PatientsCompletedNCT00334321Phase 1
- Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung CancerCompletedNCT00330044Phase 1
- Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid TreatmentStatus unknownNCT00324467Phase 2
- Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerCompletedNCT00321633Phase 2
- Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer PatientsCompletedNCT00316407Phase 1/2
- Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCTerminatedNCT00313768Phase 2
- Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung CancerCompletedNCT00308529Phase 2
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsCompletedNCT00303940Phase 1
- Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain TumorsCompletedNCT00303849Phase 1/2
- Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00298415Phase 3
- Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung CancerCompletedNCT00294931Phase 2
- Methotrexate, Mannitol, Rituximab, and Carboplatin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaStatus unknownNCT00293475Phase 1/2
- Docetaxel, Carboplatin, and Bevacizumab in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed By SurgeryTerminatedNCT00293332Phase 2
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic MelanomaCompletedNCT00288041Phase 2
- Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid TumorsCompletedNCT00287937Phase 1
- A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic IrradiationTerminatedNCT00285415Phase 2
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction CancerCompletedNCT00281788Phase 1
- Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2
- Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast CancerCompletedNCT00277069Phase 1/2
- Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell TumorsStatus unknownNCT00276718Not applicable
- Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade GliomasCompletedNCT00276640Not applicable
- Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00276588Phase 2
- Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3TerminatedNCT00273507Phase 3
- Random Trial for Elderly Patients With NSCLCStatus unknownNCT00265694Phase 3
- Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung CancerTerminatedNCT00264134Phase 1/2
- Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLCCompletedNCT00259675Phase 2
- Docetaxel in Non Small Cell Lung Cancer (NSCLC)CompletedNCT00258739Phase 2